Orticumab (MLDL1278A) is an antibody that specifically targets and inhibits oxidized or malondialdehyde-modified low-density lipoprotein (oxLDL), playing a role in the modulation of autoimmune responses against oxLDL and showing potential in improving at
CAS Number:
[1314241-10-5]
* VAT and and shipping costs not included. Errors and price changes excepted
